Related Experiment Video
Updated: Oct 2, 2026

Fluorescence-Based Measurements of Phosphatidylserine/Phosphatidylinositol 4-Phosphate Exchange Between Membranes
Published on: March 14, 2021
The redox regulation of LMW-PTP during cell proliferation or growth inhibition
1Dipartimento di Scienze Biochimiche, Universita' di Firenze, Italy. paola.chiarugi@.unifi.it
Abstract:
Low-molecular-weight protein tyrosine phosphatase (LMW-PTP) is an enzyme involved in platelet derived growth factor (PDGF)-induced mitogenesis and cytoskeleton rearrangement, because it is able to bind and dephosphorylate the activated receptor. LMW-PTP contains two cysteines located in position 12 and 17, both inside the catalytic pocket: this is a unique feature of LMW-PTP among all protein tyrosine phosphatases. LMW-PTP is oxidized and inactivated both in vitro and in vivo by exogenous oxidative stress and by endogenously generated oxidative burst produced during PDGF signaling, and recovers its activity within 40 min. The reversibility of in vivo LMW-PTP oxidation is glutathione dependent. The additional catalytic pocket cysteine, in position 17, retains an intriguing and peculiar role in the formation of a S-S intramolecular bond, which protects the catalytic Cys12 from further and irreversible oxidation. The presence of an additional cysteine near the catalytic one, confers to LMW-PTP the ability to rapidly recover its activity and finely regulate PDGF receptor activation during both extracellularly and intracellularly generated oxidative stress. In addition, redox up-regulation of LMW-PTP is involved in intracellular delivery of antiproliferative signals, as the arrest of growth induced by cell confluence and differentiation are associated with a decrease in the steady-state levels of intracellular ROS. The studies of the redox state of LMW-PTP in contact-inhibited cells and in mature myoblasts demonstrate that the protein is reduced and activated in both these conditions, thus leading to the hypothesis that LMW-PTP is a modulator of growth inhibition.
Insights
Low-molecular-weight protein tyrosine phosphatase (LMW-PTP) rapidly recovers from oxidative inactivation, a process crucial for regulating cell growth. Its unique cysteine residues protect it from irreversible damage, highlighting its role in controlling cell proliferation signals.
Area of Science:
- Biochemistry
- Cell Biology
- Enzymology
Background:
- Low-molecular-weight protein tyrosine phosphatase (LMW-PTP) is key in platelet-derived growth factor (PDGF)-induced cell signaling.
- LMW-PTP possesses a unique catalytic pocket with two cysteines (Cys12 and Cys17).
- Oxidative stress inactivates LMW-PTP, affecting PDGF receptor signaling and cell proliferation.
Purpose of the Study:
- To investigate the role of LMW-PTP's unique cysteine residues in its redox regulation.
- To understand how LMW-PTP activity is recovered after oxidative inactivation.
- To explore the connection between LMW-PTP redox state and growth inhibition signals.
Main Methods:
- In vitro and in vivo studies of LMW-PTP oxidation and reactivation.
- Assessment of glutathione's role in LMW-PTP activity recovery.
- Analysis of LMW-PTP redox state in contact-inhibited cells and differentiating myoblasts.
Main Results:
- LMW-PTP is reversibly oxidized and inactivated by oxidative stress, with recovery dependent on glutathione.
- Cys17 forms a protective disulfide bond, preventing irreversible oxidation of the catalytic Cys12.
- Activated LMW-PTP is reduced in growth-arrested states, suggesting a role in antiproliferative signaling.
Conclusions:
- LMW-PTP's unique cysteine structure enables rapid activity recovery and fine-tunes PDGF receptor signaling under oxidative stress.
- Redox regulation of LMW-PTP is implicated in mediating antiproliferative signals, including growth arrest and differentiation.
- LMW-PTP acts as a critical modulator of growth inhibition, responding to intracellular reactive oxygen species levels.
Related Concept Videos
Abnormal Proliferation
PI3K/mTOR/AKT Signaling Pathway
Regulation of Angiogenesis and Blood Supply
Anticoagulant Drugs: Low-Molecular-Weight Heparins

